Illumina Inc (ILMN.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|65||2016||Executive Chairman of the Board|
|47||2016||President, Chief Executive Officer, Director|
|47||2016||Chief Financial Officer, Senior Vice President|
|46||2016||Executive Vice President, Chief Administrative Officer|
|51||2017||Executive Vice President - Clinical Genomics|
- BRIEF-Illumina Acquires Edico Genome To Accelerate Genomic Data Analysis
- BRIEF-Caredx Inc Enters Into A License And Commercialization Agreement With Illumina
- BRIEF-Illumina Inc GAAP Earnings Per Share $1.41
- BRIEF-Bristol-Myers Squibb And Illumina Announce Collaboration To Develop Companion Diagnostics For Bristol-Myers Squibb's Oncology Immunotherapies
- Loxo, Illumina to partner for diagnostic tool targeting cancer